Analysis

There have been "stark changes" to investor behaviour recently, but beware over-confidence in the UK economy as tailwinds could soon turn to headwinds, warns Franklin Templeton's Colin Morton.

Investments in the healthcare sector have been on an upward climb in the last decade - but shares in drug companies are not the only way to play the sector. Kenneth Mackenzie from Target Advisers explains why the fundamentals for residential care stack...

Yields on blue chip equities are "staggering" and HSBC is glaringly good value, says Chris White from Premier Asset Management.

High yield investors are not being adequately compensated for liquidity risk, argues David Vickers from Russell Investments.

Year-on-year aggregate dividend growth from UK companies slowed to a sluggish 1.2% in the second quarter, according to Capita Asset Services.

Inflows to European loans have never been stronger, but some investors have been deterred by loose credit standards and terms skewed in the issuer's favour. Lyxor Asset Management UK's Thierry de Vergnes investigates the pros and cons.

Coups and crisis: Can nothing dent confidence in Asia?

Europe's small caps have had a stonking five-year rally, but as prices have come off a little since May, investors need to start separating Norway from the Netherlands, explains Bill Barker from Pictet Asset Management.

Diplomatic and territorial conflicts have been rising but defence stocks remain strangely overlooked. City Financial's Benjamin Dawes explains why cyber security and homeland defence companies are worth a punt.

The US market has confounded some observers this year. After such strong performance in 2013, when the market rose just shy of 30%, many commentators had written the market off or at least condemned it to underperformance in 2014.